DAVID HARDY: Open Payments
NPI 1083149397 · TYLER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$382 in 20 payments from 6 companies in 2025. Trend: 2023 $2,400 · 2024 $1,329 · 2025 $382
Food & beverage: $382
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 11 | $166 |
| Baxter Healthcare | 1 | $73 |
| Amgen Inc. | 4 | $64 |
| ABBVIE INC. | 2 | $41 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
Products named: LEQVIO, PERCLOT, VRAYLAR, OTEZLA, REPATHA, OFEV, CAPLYTA.
Industry payments across TX — which companies pay providers there.
